Circadian dysfunction in a rotenone-induced parkinsonian rodent model

Chronobiology International

Volumn 29, Issue 2, 2012, Pages 147-156

  Lax, Pedro ^a   Esquiva, Gema ^a   Esteve Rudd, Julian ^a   Otalora, Beatriz Bao ^b   Madrid, Juan Antoñio ^b   Cuenca, Nicolás ^a  

^a UNIVERSITY OF ALICANTE   (Spain)

^b UNIVERSITY OF MURCIA   (Spain)

Author keywords

Body temperature; Circadian rhythm; Locomotor activity; Neurodegeneration; Parkinson's disease; Rat; Rotenone

Indexed keywords

INSECTICIDE; ROTENONE;

ANIMAL; ANIMAL BEHAVIOR; ARTICLE; BIOLOGICAL RHYTHM; BODY TEMPERATURE; CHEMICALLY INDUCED DISORDER; CIRCADIAN RHYTHM; DISEASE MODEL; DRUG EFFECT; HUMAN; MOTOR ACTIVITY; PARKINSONISM; PATHOPHYSIOLOGY; RAT; SPRAGUE DAWLEY RAT;

ANIMALS; BEHAVIOR, ANIMAL; BIOLOGICAL CLOCKS; BODY TEMPERATURE; CIRCADIAN RHYTHM; DISEASE MODELS, ANIMAL; HUMANS; INSECTICIDES; MOTOR ACTIVITY; PARKINSONIAN DISORDERS; RATS; RATS, SPRAGUE-DAWLEY; ROTENONE;

ANIMALIA; PARKINSONIA; RATTUS; RODENTIA;

EID: 84856889379     PISSN: 07420528     EISSN: 15256073     Source Type: Journal    
DOI: 10.3109/07420528.2011.649870     Document Type: Article

References (57)

1. Alam M, Schmidt WJ. (2002). Rotenone destroys dopaminergic neurons and induces parkinsonian symptoms in rats. Behav. Brain Res. 136:317-324. (Pubitemid 35246417)
2. Almirall H, Bautista V, Sanchez-Bahillo A, Trinidad-HerreroM. (2001). Ultradian and circadian body temperature and activity rhythms in chronic MPTP treated monkeys. Neurophysiol. Clin. 31:161-170. (Pubitemid 32661118)
3. Ben V, Bruguerolle B. (2000). Effects of bilateral striatal 6-OHDA lesions on circadian rhythms in the rat: a radiotelemetric study. Life Sci. 67:1549-1558. (Pubitemid 30663012)
4. Ben V, Blin O, Bruguerolle B. (1999). Time-dependent striatal dopamine depletion after injection of 6-hydroxydopamine in the rat. Comparison of single bilateral and double bilateral lesions. J. Pharm. Pharmacol. 51:1405-1408. (Pubitemid 30064070)
5. Betarbet R, Sherer TB, MacKenzie G, Garcia-Osuna M, Panov AV, Greenamyre JT. (2000). Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat. Neurosci. 3:1301-1306.
6. Bodis-Wollner I. (2009). Retinopathy in Parkinson disease. J. Neural. Transm. 116:1493-1501.
7. Bordet R, Devos D, Brique S, Touitou Y, Guieu JD, Libersa C, Destee A. (2003). Study of circadian melatonin secretion pattern at different stages of Parkinson's disease. Clin. Neuropharmacol. 26:65-72. (Pubitemid 36397362)
8. Boulamery A, Simon N, Vidal J, Bruguerolle B. (2010). Effects of L-dopa on circadian rhythms of 6-OHDA striatal lesioned rats: a radiotelemetric study. Chronobiol. Int. 27:251-264.
9. Bove J, Prou D, Perier C, Przedborski S. (2005). Toxin-induced models of Parkinson's disease. NeuroRx 2:484-494. (Pubitemid 41444882)
10. Bueler H. (2009). Impaired mitochondrial dynamics and function in the pathogenesis of Parkinson's disease. Exp. Neurol. 218:235-246.
11. Cagnacci A, Bonuccelli U, Melis GB, Soldani R, Piccini P, Napolitano A, Muratorio A, Fioretti P. (1990). Effect of naloxone on body temperature in postmenopausal women with Parkinson's disease. Life Sci. 46:1241-1247. (Pubitemid 20148793)
12. Cai Y, Liu S, Sothern RB, Xu S, Chan P. (2010). Expression of clock genes Per1 and Bmal1 in total leukocytes in health and Parkinson's disease. Eur. J. Neurol. 17:550-554.
13. Carrier J, Paquet J, Morettini J, Touchette E. (2002). Phase advance of sleep and temperature circadian rhythms in the middle years of life in humans. Neurosci. Lett. 320:1-4. (Pubitemid 34159262)
14. Czeisler CA, Dumont M, Duffy JF, Steinberg JD, Richardson GS, Brown EN, Sanchez R, Rios CD, Ronda JM. (1992). Association of sleepwake habits in older people with changes in output of circadian pacemaker. Lancet 340:933-936.
15. DauerW, Przedborski S. (2003). Parkinson's disease: mechanisms and models. Neuron 39:889-909. (Pubitemid 37130207)
16. Eaker EY, Bixler GB, Dunn AJ, Moreshead WV, Mathias JR. (1987). Chronic alterations in jejunal myoelectric activity in rats due to MPTP. Am. J. Physiol. 253:G809-G815.
17. Esteve-Rudd J, Fernández-Sánchez L, Lax P, De Juan E, Martín-Nieto J, Cuenca N. (2011). Rotenone induces degeneration of photoreceptors and impairs the dopaminergic system in the rat retina. Neurobiol. Dis. 44:102-115.
18. Ferreira JJ, Desboeuf K, Galitzky M, Thalamas C, Brefel-Courbon C, Fabre N, Senard JM, Montastruc JL, Sampaio C, Rascol O. (2006). Sleep disruption, daytime somnolence and 'sleep attacks' in Parkinson's disease: a clinical survey in PD patients and agematched healthy volunteers. Eur. J. Neurol. 13:209-214.
19. Freyaldenhoven TE, Ali SF, Hart RW. (1995). MPTP- and MPP (+)-induced effects on body temperature exhibit age- and straindependence in mice. Brain Res. 688:161-170.
20. Garcia-Borreguero D, Larrosa O, Bravo M. (2003). Parkinson's disease and sleep. Sleep Med. Rev. 7:115-129. (Pubitemid 36313973)
21. Greenamyre JT, Sherer TB, Betarbet R, Panov AV. (2001). Complex I and Parkinson's disease. IUBMB Life 52:135-141. (Pubitemid 33731566)
22. Hartmann A, Veldhuis JD, Deuschle M, Standhardt H, Heuser I. (1997). Twenty-four hour cortisol release profiles in patients with Alzheimer's and Parkinson's disease compared to normal controls: ultradian secretory pulsatility and diurnal variation. Neurobiol. Aging 18:285-289. (Pubitemid 27360064)
23. Hineno T, Mizobuchi M, Hiratani K, Inami Y, Kakimoto Y. (1992). Disappearance of circadian rhythms in Parkinson's disease model induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in dogs. Brain Res. 580:92-99.
24. Hoglinger GU, Feger J, Prigent A, Michel PP, Parain K, Champy P, Ruberg M, Oertel WH, Hirsch EC. (2003). Chronic systemic complex I inhibition induces a hypokinetic multisystem degeneration in rats. J. Neurochem. 84:491-502. (Pubitemid 36182248)
25. Kuroda H, Fukushima M, Nakai M, Katayama T, Murakami N. (1997). Daily wheel running activity modifies the period of free-running rhythmin rats via intergeniculate leaflet. Physiol. Behav. 61:633-637. (Pubitemid 27208354)
26. Lax P, Otalora BB, Esquiva G, Rol Mde L, Madrid JA, Cuenca N. (2011). Circadian dysfunction in P23H rhodopsin transgenic rats: effects of exogenous melatonin. J. Pineal Res. 50:183-191.
27. Lees AJ, Blackburn NA, Campbell VL. (1988). The nighttime problems of Parkinson's disease. Clin. Neuropharmacol. 11:512-519. (Pubitemid 19006460)
28. Miller DB, O'Callaghan JP. (1994). Environment-, drug- and stressinduced alterations in body temperature affect the neurotoxicity of substituted amphetamines in the C57BL/6J mouse. J. Pharmacol. Exp. Ther. 270:752-760. (Pubitemid 24271392)
29. Mizuno Y, Ohta S, Tanaka M, Takamiya S, Suzuki K, Sato T, Oya H, Ozawa T, Kagawa Y. (1989). Deficiencies in complex I subunits of the respiratory chain in Parkinson's disease. Biochem. Biophys. Res. Commun. 163:1450-1455. (Pubitemid 19244751)
30. Olbrich D, Dittmar M. (2011). Older poor sleeping women display a smaller evening increase in melatonin secretion and lower values of melatonin and core body temperature than good sleepers. Chronobiol. Int. 28:681-689.
31. Ortiz-Tudela E, Martinez-Nicolas A, Campos M, Rol MA, Madrid JA. (2010). A new integrated variable based on thermometry, actimetry and body position (TAP) to evaluate circadian system status in humans. PLoS Comput. Biol. 6:e1000996.
32. Otalora BB, Madrid JA, Alvarez N, Vicente V, Rol MA. (2008). Effects of exogenous melatonin and circadian synchronization on tumor progression in melanoma-bearing C57BL6 mice. J. Pineal Res. 44:307-315. (Pubitemid 351392944)
33. ParkerWDJr, Boyson SJ, Parks JK. (1989). Abnormalities of the electron transport chain in idiopathic Parkinson's disease. Ann. Neurol. 26:719-723. (Pubitemid 20011004)
34. Pierangeli G, Provini F, Maltoni P, Barletta G, Contin M, Lugaresi E, Montagna P, Cortelli P. (2001). Nocturnal body core temperature falls in Parkinson's disease but not in multiple-system atrophy. Mov. Disord. 16:226-232. (Pubitemid 36049969)
35. Portaluppi F, Smolensky MH, Touitou Y. (2010). Ethics and methods for biological rhythm research on animals and human beings. Chronobiol. Int. 27:1911-1929.
36. Paudel ML, Taylor BC, Ancoli-Israel S, Blackwell T, Stone KL, Tranah G, Redline S, Cummings SR, Ensrud KE for the Osteoportic Fractures in Men (MeOS) Study Group. (2010). Rest/activity rhythms and mortality rates in older men: MrOS Sleep Study. Chronobiol. Int. 27:363-377.
37. Paudel ML, Taylor BC, Ancoli-Israel S, Stone KL, Tranah G, Redline S, Barrett-Connor E, Stefanick ML, Ensrud KE for the Osteoportic Fractures in Men (MeOS) Study Group. (2011). Rest/activity rhythms and cardiovascualr disease in older men. Chronobiol. Int. 28:258-266.
38. Pursiainen V, Haapaniemi TH, Korpelainen JT, Huikuri HV, Sotaniemi KA, Myllyla VV. (2002). Circadian heart rate variability in Parkinson's disease. J. Neurol. 249:1535-1540. (Pubitemid 35477895)
39. Schapira AH. (1998). Human complex I defects in neurodegenerative diseases. Biochim. Biophys. Acta 1364:261-270. (Pubitemid 28291844)
40. Schober A. (2004). Classic toxin-induced animal models of Parkinson's disease: 6-OHDA and MPTP. Cell Tissue Res. 318:215-224. (Pubitemid 39366054)
41. Sherer TB, Betarbet R, Testa CM, Seo BB, Richardson JR, Kim JH, Miller GW, Yagi T, Matsuno-Yagi A, Greenamyre JT. (2003a). Mechanism of toxicity in rotenone models of Parkinson's disease. J. Neurosci. 23:10756-10764. (Pubitemid 37499681)
42. Sherer TB, Kim JH, Betarbet R, Greenamyre JT. (2003b). Subcutaneous rotenone exposure causes highly selective dopaminergic degeneration and alpha-synuclein aggregation. Exp. Neurol. 179:9-16. (Pubitemid 36062614)
43. Sindhu KM, Saravanan KS, Mohanakumar KP. (2005). Behavioral differences in a rotenone-induced hemiparkinsonian rat model developed following intranigral or median forebrain bundle infusion. Brain Res. 1051:25-34. (Pubitemid 40982623)
44. Tatton WG, Kwan MM, Verrier MC, Seniuk NA, Theriault E. (1990). MPTP produces reversible disappearance of tyrosine hydroxylasecontaining retinal amacrine cells. Brain Res. 527:21-31. (Pubitemid 20290580)
45. Terzioglu M, Galter D. (2008). Parkinson's disease: genetic versus toxin-induced rodent models. FEBS J. 275:1384-1391. (Pubitemid 351388790)
46. Uversky VN. (2004). Neurotoxicant-induced animal models of Parkinson's disease: understanding the role of rotenone, maneb and paraquat in neurodegeneration. Cell Tissue Res. 318:225-41. (Pubitemid 39362642)
47. van Hilten JJ, Weggeman M, van der Velde EA, Kerkhof GA, van Dijk JG, Roos RA. (1993). Sleep, excessive daytime sleepiness and fatigue in Parkinson's disease. J. Neural Transm. Park. Dis. Dement. Sect. 5:235-244. (Pubitemid 23227817)
48. van Hilten B, Hoff JI, Middelkoop HA, van der Velde EA, Kerkhof GA, Wauquier A, Kamphuisen HA, Roos RA. (1994). Sleep disruption in Parkinson's disease. Assessment by continuous activity monitoring. Arch. Neurol. 51:922-928. (Pubitemid 24286048)
49. Vila M, Przedborski S. (2004). Genetic clues to the pathogenesis of Parkinson's disease. Nat. Med. 10(Suppl):S58-S62. (Pubitemid 38901868)
50. Whitehead DL, Davies AD, Playfer JR, Turnbull CJ. (2008). Circadian rest-activity rhythm is altered in Parkinson's disease patients with hallucinations. Mov. Disord. 23:1137-1145.
51. Willis GL. (2008a). Intraocular microinjections repair experimental Parkinson's disease. Brain Res. 1217:119-131.
52. Willis GL. (2008b). Parkinson's disease as a neuroendocrine disorder of circadian function: dopamine-melatonin imbalance and the visual system in the genesis and progression of the degenerative process. Rev. Neurosci. 19:245-316.
53. Willis GL, Armstrong SM. (2010). New vistas on Parkinson's disease. Eur. J. Neurol. 17:519-520.
54. Willis GL, Turner EJ. (2007). Primary and secondary features of Parkinson's disease improve with strategic exposure to bright light: a case series study. Chronobiol. Int. 24:521-537. (Pubitemid 47026954)
55. Witkovsky P. (2004). Dopamine and retinal function. Doc. Ophthalmol. 108:17-40. (Pubitemid 38461014)
56. Yamada N, Shimoda K, Ohi K, Takahashi S, Takahashi K. (1988). Freeaccess to a running wheel shortens the period of free-running rhythm in blinded rats. Physiol. Behav. 42:87-91. (Pubitemid 18050894)
57. Yamada N, Shimoda K, Takahashi K, Takahashi S. (1990). Relationship between free-running period and motor activity in blinded rats. Brain Res. Bull. 25:115-119. (Pubitemid 20246623)